Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032577 · ClinicalTrials.gov registry record
A Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations
A clinical trial, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- 50
- Enrollment target
NCT01032577 is a clinical trial that has completed, run by Trinity Health Of New England. The registered enrollment target is 50 participants.
The verdict
NCT01032577 has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The PropR study will evaluate sensing during ventricular fibrillation (VF) in both bipolar and extended bipolar configurations, in order to evaluate if both can be used interchangeably in caring for patients. In addition, follow up evaluation of R wave amplitude over time would allow us to determine whether one configuration is more likely to be associated with change. This understanding would be important in selecting the proper configuration at the time of implant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01032577
The ClinicalTrials.gov registry entry for NCT01032577 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01032577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01032577 about?
NCT01032577 is a clinical study titled "A Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations". The PropR study will evaluate sensing during ventricular fibrillation (VF) in both bipolar and extended bipolar configurations, in order to evaluate if both can be used interchangeably in caring for patients. In addition, follow up evaluation of R wave amplitude over time would allow us to determine...
What is the current status of trial NCT01032577?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-12. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01032577?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.